John Hussman's REGN Position Overview
John Hussman (via Hussman Strategic Advisors, Inc.) currently holds 5,250 shares of Regeneron Pharmaceuticals, Inc. (REGN) worth $3.27 M, representing 0.75% of the portfolio. First purchased in 2019-Q1, this long-term strategic position has been held for 22 quarters.
Based on 13F filings, John Hussman has maintained a strategic position in REGN, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2026, adding 5,250 shares. Largest reduction occurred in Q3 2020, reducing 4,100 shares.
Analysis based on 13F filings available since 2013 Q2
John Hussman's Regeneron Pharmaceuticals (REGN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Regeneron Pharmaceuticals (REGN) Trades by John Hussman
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +5,250 | New Buy | 5,250 | $623.54 |
| Q2 2025 | -2,100 | Sold Out | 0 | $0.00 |
| Q4 2024 | +2,100 | New Buy | 2,100 | $712.33 |
| Q2 2024 | -2,100 | Sold Out | 0 | $0.00 |
| Q1 2024 | -2,100 | Reduce 50.00% | 2,100 | $962.49 |
| Q3 2023 | -3,600 | Reduce 46.15% | 4,200 | $822.96 |
| Q4 2022 | -1,500 | Reduce 16.13% | 7,800 | $721.49 |
| Q3 2022 | -1,050 | Reduce 10.14% | 9,300 | $688.82 |
| Q2 2022 | +4,110 | Add 65.87% | 10,350 | $591.11 |
| Q1 2022 | +1,040 | Add 20.00% | 6,240 | $698.40 |
| Q4 2021 | +5,200 | New Buy | 5,200 | $631.54 |
| Q3 2020 | -4,100 | Sold Out | 0 | $0.00 |
| Q1 2020 | +1,600 | Add 64.00% | 4,100 | $488.29 |
| Q4 2019 | -2,500 | Reduce 50.00% | 2,500 | $375.60 |
| Q2 2019 | -2,500 | Reduce 33.33% | 5,000 | $313.00 |
| Q1 2019 | +7,500 | New Buy | 7,500 | $410.67 |
John Hussman's Regeneron Pharmaceuticals Investment FAQs
John Hussman first purchased Regeneron Pharmaceuticals, Inc. (REGN) in Q1 2019, acquiring 7,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Hussman has held Regeneron Pharmaceuticals, Inc. (REGN) for 22 quarters since Q1 2019.
John Hussman's largest addition to Regeneron Pharmaceuticals, Inc. (REGN) was in Q1 2019, adding 7,500 shares worth $3.08 M.
According to the latest 13F filing for Q2 2026, John Hussman's firm, Hussman Strategic Advisors, Inc., owns 5,250 shares of Regeneron Pharmaceuticals, Inc. (REGN), valued at approximately $3.27 M.
As of the Q2 2026 filing, Regeneron Pharmaceuticals, Inc. (REGN) represents approximately 0.75% of John Hussman's publicly disclosed stock portfolio, making it one of their key holdings.
John Hussman's peak holding in Regeneron Pharmaceuticals, Inc. (REGN) was 10,350 shares, as reported at the end of Q2 2022.